Bringing the fundamentals into focus…
Back to Haleon plc
How Haleon plc stacks up
HLN · against 454 other Healthcare companies listed in US-listed
Growth
36/ 100
Below the middle of the pack.
Ranked #330 of 455 · scores higher than 27% of peers
Bars: peers in each 10-point band of the growth score32 peers with a growth score of 30–39, including HLN · Click a bar to see the companies
Why growth scores 36?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 73% of peers. Revenue growth: -1.8% vs peer median 6.1%
- slower revenue growth over three years: weaker than 70% of peers. 3-year revenue growth: 0.5% vs peer median 5.8%
- Earnings per share growth is close to the peer norm. Earnings per share growth: 17.3% vs peer median 9.8%
Metric by metric
Position: dot = HLN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | HLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | -1.8% | 11.0% | 21% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 17.3% | 21.2% | 45% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 0.5% | 11.0% | 21% | 33% |
Ranking by growth score
Top 5 and the companies ranked around HLN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 460M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 441M USD | 99 | 81 | |
| 2 | 9.5B USD | 99 | 31 | |
| 2 | 87M USD | 99 | 27 | |
| 324 | 367.5B USD | 38 | 47 | |
| 328 | 11.1B USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score